Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Diagnosing new systemic lupus during pregnancy is hard but important for the health of the mother and baby.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Tofacitinib helped regrow hair in most patients with severe hair loss.

The research provides insights into hair follicle growth in forest musk deer by identifying key genes and pathways involved.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Glycyrrhizic acid and licorice extract can significantly reduce unwanted hair growth.

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.

Hormones affect skin aging, and treatments targeting hormonal balance may improve skin health.

Aging causes hair to gray and thin, with the timing of graying varying by race, and factors like oxidative stress and genetics can lead to hair loss.

The document shows the state of pharmaceutical patents as of 1999, focusing on treatments for various diseases.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Follistatin is important for hair growth and could help treat hair loss.

VEGF helps hair grow and determines follicle size by increasing blood vessel growth.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Stem cell niches support, regulate, and coordinate stem cell functions.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

The p75 neurotrophin receptor is important for hair follicle regression by controlling cell death.

Certain genes control the color of human hair by affecting pigment production.

Some common medications can harm male fertility, but many effects can be reversed.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.